-
If you purchased shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) and currently hold any of those NASDAQ:AMRI shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
June 15, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Albany Molecular Research, Inc. (NASDAQ:AMRI), was announced concerning whether the takeover of Albany Molecular Research, Inc. by The Carlyle Group and GTCR LLC for $21.75 per share is unfair to NASDAQ:AMRI stockholders. The investigation by a law firm concerns whether ce...
You must register (for free) or login to view the entire investigation.
